Sono-Tek Corporation reported its financial results for the third quarter and first nine months of fiscal year 2026, showing consistent revenue performance and significant growth in net income.
The company's gross margin expanded to 50% in the quarter and 51% year-to-date, reflecting improved profitability.
Net income increased by 24% in the third quarter and 32% in the first nine months, signaling sustainable financial progress.
Seventh Consecutive Quarter of Revenue Over $5 Million
Sono-Tek achieved a revenue milestone with the seventh consecutive quarter of revenue exceeding $5 million, driven by strong performance in the medical market and high-ASP production systems.
Record Backlog of $12.3 Million
The company's backlog reached a record $12.3 million, showcasing continued order momentum and strong customer confidence in Sono-Tek's technology.
Gross Margin Expansion
Gross margin expanded to 50% in the quarter and 51% year-to-date, indicating improved profitability and successful cost management strategies.
Guidance for Fiscal Year 2026
Sono-Tek reiterates its full-year guidance with modest revenue growth, balancing market adjustments and growing demand in the medical device market.
- Sono-Tek's financial results demonstrate steady growth with consistent revenue performance and significant margin expansion.
- The company's focus on high-ASP production systems and disciplined cost management has led to improved profitability and sustained customer confidence.
- Strong demand in the medical market and increasing adoption of advanced ultrasonic coating platforms contribute to Sono-Tek's positive outlook for future growth.
Sono-Tek's financial performance in the third quarter and first nine months of fiscal year 2026 reflects a resilient business strategy, strong market positioning, and consistent growth trajectory.